Research Progress in the Development of Vaccines against Mycoplasma gallisepticum and Mycoplasma synoviae
Abstract
:1. Introduction
2. Conventional Vaccines
2.1. Inactivated Vaccine
2.2. Live Attenuated Vaccines
3. Genetic Engineering Vaccine
3.1. Subunit Vaccine
3.2. Recombinant Vector Live Vaccine
3.3. Gene Deletion Vaccine
3.4. Immune Program and Immunologic Adjuvant
4. Prospects and Summary
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Marouf, S.; Khalf, M.A.; Alorabi, M.; El-Shehawi, A.M.; El-Tahan, A.M.; El-Hack, M.E.A.; El-Saadony, M.T.; Salem, H.M. Mycoplasma gallisepticum: A devastating organism for the poultry industry in Egypt. Poult. Sci. 2022, 101, 101658. [Google Scholar] [CrossRef] [PubMed]
- Samy, A.; Naguib, M.M. Avian Respiratory Coinfection and Impact on Avian Influenza Pathogenicity in Domestic Poultry: Field and Experimental Findings. Vet. Sci. 2018, 5, 23. [Google Scholar] [CrossRef] [PubMed]
- Lockaby, S.B.; Hoerr, F.J.; Lauerman, L.H.; Smith, B.F.; Samoylov, A.M.; Toivio-Kinnucan, M.A.; Kleven, S.H. Factors associated with virulence of Mycoplasma synoviae. Avian Dis. 1999, 43, 251–261. [Google Scholar] [CrossRef]
- Papazisi, L.; Gorton, T.S.; Kutish, G.; Markham, P.F.; Browning, G.F.; Nguyen, D.K.; Swartzell, S.; Madan, A.; Mahairas, G.; Geary, S.J. The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology 2003, 149, 2307–2316. [Google Scholar] [CrossRef] [PubMed]
- Osman, K.M.; Aly, M.M.; Amin, Z.M.; Hasan, B.S. Mycoplasma gallisepticum: An emerging challenge to the poultry industry in Egypt. Rev. Sci. Tech. 2009, 28, 1015–1023. [Google Scholar] [CrossRef] [PubMed]
- Ferguson-Noel, N.; Cookson, K.; Laibinis, V.A.; Kleven, S.H. The efficacy of three commercial Mycoplasma gallisepticum vaccines in laying hens. Avian Dis. 2012, 56, 272–275. [Google Scholar] [CrossRef]
- Jacob, R.; Branton, S.L.; Evans, J.D.; Leigh, S.A.; Peebles, E.D. Effects of live and killed vaccines against Mycoplasma gallisepticum on the performance characteristics of commercial layer chickens. Poult. Sci. 2014, 93, 1403–1409. [Google Scholar] [CrossRef] [PubMed]
- Marouf, S.; Ibrahim, H.M.; El-Naggar, M.S.; Swelum, A.A.; Alqhtani, A.H.; El-Saadony, M.T.; El-Tarabily, K.A.; Salem, H.M. Inactivated pentavalent vaccine against mycoplasmosis and salmonellosis for chickens. Poult. Sci. 2022, 101, 102139. [Google Scholar] [CrossRef] [PubMed]
- Gong, X.; Chen, Q.; Ferguson-Noel, N.; Stipkovits, L.; Szathmary, S.; Liu, Y.; Zheng, F. Evaluation of protective efficacy of inactivated Mycoplasma synoviae vaccine with different adjuvants. Vet. Immunol. Immunopathol. 2020, 220, 109995. [Google Scholar] [CrossRef]
- Kleven, S.H. Control of avian mycoplasma infections in commercial poultry. Avian Dis. 2008, 52, 367–374. [Google Scholar] [CrossRef]
- Cummings, T.S.; Kleven, S.H. Evaluation of protection against Mycoplasma gallisepticum infection in chickens vaccinated with the F strain of M. gallisepticum. Avian Dis. 1986, 30, 169–171. [Google Scholar] [CrossRef] [PubMed]
- Whithear, K.G.; Soeripto; Harrigan, K.E.; Ghiocas, E. Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust. Vet. J. 1990, 67, 168–174. [Google Scholar] [CrossRef] [PubMed]
- Abd-el-Motelib, T.Y.; Kleven, S.H. A comparative study of Mycoplasma gallisepticum vaccines in young chickens. Avian Dis. 1993, 37, 981–987. [Google Scholar] [CrossRef] [PubMed]
- Mugunthan, S.P.; Kannan, G.; Chandra, H.M.; Paital, B. Infection, Transmission, Pathogenesis and Vaccine Development against Mycoplasma gallisepticum. Vaccines 2023, 11, 469. [Google Scholar] [CrossRef]
- Ishfaq, M.; Hu, W.; Khan, M.Z.; Ahmad, I.; Guo, W.; Li, J. Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum. Poult. Sci. 2020, 99, 4195–4202. [Google Scholar] [CrossRef]
- Bwala, D.G.; Solomon, P.; Duncan, N.; Wandrag, D.B.R.; Abolnik, C. Assessment of Mycoplasma gallisepticum vaccine efficacy in a co-infection challenge model with QX-like infectious bronchitis virus. Avian Pathol. 2018, 47, 261–270. [Google Scholar] [CrossRef]
- Ferguson-Noel, N.M.; Williams, S.M. The efficacy of Mycoplasma gallisepticum K-strain live vaccine in broiler and layer chickens. Avian Pathol. 2015, 44, 75–80. [Google Scholar] [CrossRef]
- Kanci, A.; Wijesurendra, D.S.; Wawegama, N.K.; Underwood, G.J.; Noormohammadi, A.H.; Markham, P.F.; Browning, G.F. Evaluation of Mycoplasma gallisepticum (MG) ts-304 vaccine as a live attenuated vaccine in turkeys. Vaccine 2018, 36, 2487–2493. [Google Scholar] [CrossRef]
- Khalifa, R.; Eissa, S.; El-Hariri, M.; Refai, M. Sequencing analysis of Mycoplasma gallisepticum wild strains in vaccinated chicken breeder flocks. J. Mol. Microbiol. Biotechnol. 2014, 24, 98–104. [Google Scholar] [CrossRef]
- El Gazzar, M.; Laibinis, V.A.; Ferguson-Noel, N. Characterization of a ts-1-like Mycoplasma galisepticum isolate from commercial broiler chickens. Avian Dis. 2011, 55, 569–574. [Google Scholar] [CrossRef] [PubMed]
- Ghanem, M.; Wang, L.; Zhang, Y.; Edwards, S.; Lu, A.; Ley, D.; El-Gazzar, M. Core Genome Multilocus Sequence Typing: A Standardized Approach for Molecular Typing of Mycoplasma gallisepticum. J. Clin. Microbiol. 2018, 56, e01145-17. [Google Scholar] [CrossRef] [PubMed]
- Papazisi, L.; Silbart, L.K.; Frasca, S.; Rood, D.; Liao, X.; Gladd, M.; Javed, M.A.; Geary, S.J. A modified live Mycoplasma gallisepticum vaccine to protect chickens from respiratory disease. Vaccine 2002, 20, 3709–3719. [Google Scholar] [CrossRef]
- Gates, A.E.; Frasca, S.; Nyaoke, A.; Gorton, T.S.; Silbart, L.K.; Geary, S.J. Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis. Vaccine 2008, 26, 2010–2019. [Google Scholar] [CrossRef] [PubMed]
- Papazisi, L.; Frasca, S., Jr.; Gladd, M.; Liao, X.; Yogev, D.; Geary, S.J. GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence. Infect. Immun. 2002, 70, 6839–6845. [Google Scholar] [CrossRef] [PubMed]
- Hudson, P.; Gorton, T.S.; Papazisi, L.; Cecchini, K.; Frasca, S., Jr.; Geary, S.J. Identification of a virulence-associated determinant, dihydrolipoamide dehydrogenase (lpd), in Mycoplasma gallisepticum through in vivo screening of transposon mutants. Infect. Immun. 2006, 74, 931–939. [Google Scholar] [CrossRef]
- Kanci Condello, A.; Wawegama, N.K.; Ekanayake, D.; Zhu, L.; Tivendale, K.A.; Shil, P.K.; Daly, J.; Mohotti, S.; Todhunter, P.; Underwood, G.J.; et al. Evaluation of the safety and efficacy of the novel Mycoplasma gallisepticum vaccine, Vaxsafe MG304, after spray-vaccination of 1-day-old specific pathogen-free chicks. Vet. Microbiol. 2024, 293, 110093. [Google Scholar] [CrossRef] [PubMed]
- Noormohammadi, A.H.; Browning, G.F.; Jones, J.; Whithear, K.G. Improved detection of antibodies to Mycoplasma synoviae vaccine MS-H using an autologous recombinant MSPB enzyme-linked immunosorbent assay. Avian Pathol. 2002, 31, 611–617. [Google Scholar] [CrossRef] [PubMed]
- Feberwee, A.; Morrow, C.J.; Ghorashi, S.A.; Noormohammadi, A.H.; Landman, W.J. Effect of a live Mycoplasma synoviae vaccine on the production of eggshell apex abnormalities induced by a M. synoviae infection preceded by an infection with infectious bronchitis virus D1466. Avian Pathol. 2009, 38, 333–340. [Google Scholar] [CrossRef] [PubMed]
- Zhang, G.Z.; Zhang, R.; Zhao, H.L.; Wang, X.T.; Zhang, S.P.; Li, X.J.; Qin, C.Z.; Lv, C.M.; Zhao, J.X.; Zhou, J.F. A safety assessment of a fowlpox-vectored Mycoplasma gallisepticum vaccine in chickens. Poult. Sci. 2010, 89, 1301–1306. [Google Scholar] [CrossRef]
- Knudtson, K.L.; Minion, F.C. Construction of Tn4001lac derivatives to be used as promoter probe vectors in mycoplasmas. Gene 1993, 137, 217–222. [Google Scholar] [CrossRef] [PubMed]
- Zhang, D.; Long, Y.; Li, M.; Gong, J.; Li, X.; Lin, J.; Meng, J.; Gao, K.; Zhao, R.; Jin, T. Development and evaluation of novel recombinant adenovirus-based vaccine candidates for infectious bronchitis virus and Mycoplasma gallisepticum in chickens. Avian Pathol. 2018, 47, 213–222. [Google Scholar] [CrossRef]
- Zhang, L. Multi-epitope vaccines: A promising strategy against tumors and viral infections. Cell Mol. Immunol. 2018, 15, 182–184. [Google Scholar] [CrossRef] [PubMed]
- Han, S.; Wang, Y.; Chang, W.; Wang, L.; Fang, J.; Han, J.; Hou, X.; Qi, X.; Wang, J. Evaluation of the protective efficacy of six major immunogenic proteins of Mycoplasma synoviae. Front. Vet. Sci. 2023, 10, 1334638. [Google Scholar] [CrossRef] [PubMed]
- Bao, S.; Guo, X.; Yu, S.; Ding, J.; Tan, L.; Zhang, F.; Sun, Y.; Qiu, X.; Chen, G.; Ding, C. Mycoplasma synoviae enolase is a plasminogen/fibronectin binding protein. BMC Vet. Res. 2014, 10, 223. [Google Scholar] [CrossRef] [PubMed]
- Qi, J.; Wang, Y.; Li, H.; Shang, Y.; Gao, S.; Ding, C.; Liu, X.; Wang, S.; Li, T.; Tian, M.; et al. Mycoplasma synoviae dihydrolipoamide dehydrogenase is an immunogenic fibronectin/plasminogen binding protein and a putative adhesin. Vet. Microbiol. 2022, 265, 109328. [Google Scholar] [CrossRef] [PubMed]
- Sun, Q.; Wei, X.; Chen, W.; Zhong, Q.; Yan, Z.; Zhou, Q.; Cao, Y.; Chen, F. Characterization and Evaluation of a Novel Conserved Membrane Antigen P35 of Mycoplasma synoviae. Front. Vet. Sci. 2022, 9, 836110. [Google Scholar] [CrossRef] [PubMed]
- Hu, Z.; Li, H.; Zhao, Y.; Wang, G.; Shang, Y.; Chen, Y.; Wang, S.; Tian, M.; Qi, J.; Yu, S. NADH oxidase of Mycoplasma synoviae is a potential diagnostic antigen, plasminogen/fibronectin binding protein and a putative adhesin. BMC Vet. Res. 2022, 18, 455. [Google Scholar] [CrossRef] [PubMed]
- Zhang, G.; Han, L.; Li, Z.; Chen, Y.; Li, Q.; Wang, S.; Shi, H. Screening of immunogenic proteins and evaluation of vaccine candidates against Mycoplasma synoviae. NPJ Vaccines 2023, 8, 121. [Google Scholar] [CrossRef]
- Yano, A.; Onozuka, A.; Asahi-Ozaki, Y.; Imai, S.; Hanada, N.; Miwa, Y.; Nisizawa, T. An ingenious design for peptide vaccines. Vaccine 2005, 23, 2322–2326. [Google Scholar] [CrossRef]
- Negahdaripour, M.; Nezafat, N.; Eslami, M.; Ghoshoon, M.B.; Shoolian, E.; Najafipour, S.; Morowvat, M.H.; Dehshahri, A.; Erfani, N.; Ghasemi, Y. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. Infect. Genet. Evol. 2018, 58, 96–109. [Google Scholar] [CrossRef]
- Yano, A.; Miwa, Y.; Kanazawa, Y.; Ito, K.; Makino, M.; Imai, S.; Hanada, N.; Nisizawa, T. A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines. Vaccine 2013, 31, 1510–1515. [Google Scholar] [CrossRef]
- Zhang, G.; Han, L.; Zhao, Y.; Li, Q.; Wang, S.; Shi, H. Development and evaluation of a multi-epitope subunit vaccine against Mycoplasma synoviae infection. Int. J. Biol. Macromol. 2023, 253, 126685. [Google Scholar] [CrossRef]
- Mugunthan, S.P.; Mani Chandra, H. A Computational Reverse Vaccinology Approach for the Design and Development of Multi-Epitopic Vaccine against Avian Pathogen Mycoplasma gallisepticum. Front. Vet. Sci. 2021, 8, 721061. [Google Scholar] [CrossRef] [PubMed]
- Mugunthan, S.P.; Harish, M.C. Multi-epitope-Based Vaccine Designed by Targeting Cytoadherence Proteins of Mycoplasma gallisepticum. ACS Omega 2021, 6, 13742–13755. [Google Scholar] [CrossRef]
- Peyret, H.; Steele, J.F.C.; Jung, J.W.; Thuenemann, E.C.; Meshcheriakova, Y.; Lomonossoff, G.P. Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult. Vaccines 2021, 9, 780. [Google Scholar] [CrossRef]
- Mugunthan, S.P.; Venkatesan, D.; Govindasamy, C.; Selvaraj, D.; Mani Chandra, H. A preliminary study of the immunogenic response of plant-derived multi-epitopic peptide vaccine candidate of Mycoplasma gallisepticum in chickens. Front. Plant Sci. 2023, 14, 1298880. [Google Scholar] [CrossRef]
- Zhao, B.; Guo, Y.; Sun, R.; Zhang, L.; Yang, L.; Mei, X.; Zhang, L.; Huang, J. Quadrivalent hemagglutinin and adhesion expressed on Saccharomyces cerevisiae induce protective immunity against Mycoplasma gallisepticum infection and improve gut microbiota. Microb. Pathog. 2024, 187, 106511. [Google Scholar] [CrossRef]
- Muneta, Y.; Panicker, I.S.; Kanci, A.; Craick, D.; Noormohammadi, A.H.; Bean, A.; Browning, G.F.; Markham, P.F. Development and immunogenicity of recombinant Mycoplasma gallisepticum vaccine strain ts-11 expressing chicken IFN-gamma. Vaccine 2008, 26, 5449–5454. [Google Scholar] [CrossRef]
- Tseng, C.W.; Chiu, C.J.; Kanci, A.; Noormohammadi, A.H.; Browning, G.F.; Markham, P.F. Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate. Vaccine 2017, 35, 6248–6253. [Google Scholar] [CrossRef]
- Gates, D.E.; Staley, M.; Tardy, L.; Giraudeau, M.; Hill, G.E.; McGraw, K.J.; Bonneaud, C. Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease. Sci. Rep. 2021, 11, 8209. [Google Scholar] [CrossRef]
- Leigh, S.A.; Evans, J.D.; Branton, S.L. Complete Genome Sequences of Two Mycoplasma gallisepticum F-Strain Variants. Microbiol. Resour. Announc. 2019, 8, e00485-19. [Google Scholar] [CrossRef]
- Leigh, S.A.; Evans, J.D.; Collier, S.D.; Branton, S.L. The impact of vaccination route on Mycoplasma gallisepticum vaccine efficacy. Poult. Sci. 2018, 97, 3072–3075. [Google Scholar] [CrossRef]
- Arunachalam, P.S.; Walls, A.C.; Golden, N.; Atyeo, C.; Fischinger, S.; Li, C.; Aye, P.; Navarro, M.J.; Lai, L.; Edara, V.V.; et al. Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates. bioRxiv 2021. bioRxiv:02.10.430696. [Google Scholar]
- Jeong, S.K.; Heo, Y.K.; Jeong, J.H.; Ham, S.J.; Yum, J.S.; Ahn, B.C.; Song, C.S.; Chun, E.Y. COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity. Vaccines 2021, 9, 957. [Google Scholar] [CrossRef]
- Limsatanun, A.; Sasipreeyajan, J.; Pakpinyo, S. The Efficacy of Chitosan-Adjuvanted, Mycoplasma gallisepticum Bacterin in Chickens. Avian Dis. 2016, 60, 799–804. [Google Scholar] [CrossRef] [PubMed]
- Limsatanun, A.; Sasipreeyajan, J.; Pakpinyo, S. Chitosan-adjuvanted Mycoplasma gallisepticum bacterin via intraocular administration enhances Mycoplasma gallisepticum protection in commercial layers. Poult. Sci. 2018, 97, 1934–1940. [Google Scholar] [CrossRef] [PubMed]
- Jan, G.; Le Henaff, M.; Fontenelle, C.; Wroblewski, H. Biochemical and antigenic characterisation of Mycoplasma gallisepticum membrane proteins P52 and P67 (pMGA). Arch. Microbiol. 2001, 177, 81–90. [Google Scholar] [CrossRef] [PubMed]
- Tan, L.; Hu, M.; Yu, S.; Wang, X.; Lu, F.; Liu, F.; Qiu, X.; Song, C.; Sun, Y.; Ding, C. Characterization of the chaperonin GroEL in Mycoplasma gallisepticum. Arch. Microbiol. 2015, 197, 235–244. [Google Scholar] [CrossRef] [PubMed]
- Bercic, R.L.; Slavec, B.; Lavric, M.; Narat, M.; Bidovec, A.; Dovc, P.; Bencina, D. Identification of major immunogenic proteins of Mycoplasma synoviae isolates. Vet. Microbiol. 2008, 127, 147–154. [Google Scholar] [CrossRef] [PubMed]
- Hasan, M.; Ghosh, P.P.; Azim, K.F.; Mukta, S.; Abir, R.A.; Nahar, J.; Hasan Khan, M.M. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus. Microb. Pathog. 2019, 130, 19–37. [Google Scholar] [CrossRef]
- Madlala, T.; Adeleke, V.T.; Fatoba, A.J.; Okpeku, M.; Adeniyi, A.A.; Adeleke, M.A. Designing multiepitope-based vaccine against Eimeria from immune mapped protein 1 (IMP-1) antigen using immunoinformatic approach. Sci. Rep. 2021, 11, 18295. [Google Scholar] [CrossRef] [PubMed]
- Zai, X.; Shi, B.; Shao, H.; Qian, K.; Ye, J.; Yao, Y.; Nair, V.; Qin, A. Identification of a Novel Insertion Site HVT-005/006 for the Generation of Recombinant Turkey Herpesvirus Vector. Front. Microbiol. 2022, 13, 886873. [Google Scholar] [CrossRef] [PubMed]
- Tsukamoto, K.; Saito, S.; Saeki, S.; Sato, T.; Tanimura, N.; Isobe, T.; Mase, M.; Imada, T.; Yuasa, N.; Yamaguchi, S. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J. Virol. 2002, 76, 5637–5645. [Google Scholar] [CrossRef]
- Shi, B.; Yang, G.; Xiao, Y.; Qian, K.; Shao, H.; Xu, M.; Qin, A. Long-Term Protection against Virulent Newcastle Disease Virus (NDV) in Chickens Immunized with a Single Dose of Recombinant Turkey Herpesvirus Expressing NDV F Protein. Vaccines 2024, 12, 604. [Google Scholar] [CrossRef]
- Tang, N.; Zhang, Y.; Sadigh, Y.; Moffat, K.; Shen, Z.; Nair, V.; Yao, Y. Generation of a Triple Insert Live Avian Herpesvirus Vectored Vaccine Using CRISPR/Cas9-Based Gene Editing. Vaccines 2020, 8, 97. [Google Scholar] [CrossRef] [PubMed]
- Fagan, P.K.; Djordjevic, S.P.; Chin, J.; Eamens, G.J.; Walker, M.J. Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF). Infect. Immun. 1997, 65, 2502–2507. [Google Scholar] [CrossRef] [PubMed]
- Okamba, F.R.; Arella, M.; Music, N.; Jia, J.J.; Gottschalk, M.; Gagnon, C.A. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Vaccine 2010, 28, 4802–4809. [Google Scholar] [CrossRef] [PubMed]
- Barate, A.K.; Cho, Y.; Truong, Q.L.; Hahn, T.W. Immunogenicity of IMS 1113 plus soluble subunit and chimeric proteins containing Mycoplasma hyopneumoniae P97 C-terminal repeat regions. FEMS Microbiol. Lett. 2014, 352, 213–220. [Google Scholar] [CrossRef]
- Ishag, H.Z.; Wu, Y.Z.; Liu, M.J.; Xiong, Q.Y.; Feng, Z.X.; Yang, R.S.; Shao, G.Q. In vitro protective efficacy of Lithium chloride against Mycoplasma hyopneumoniae infection. Res. Vet. Sci. 2016, 106, 93–96. [Google Scholar] [CrossRef]
- Virginio, V.G.; Bandeira, N.C.; Leal, F.M.; Lancellotti, M.; Zaha, A.; Ferreira, H.B. Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines. Heliyon 2017, 3, e00225. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wu, S.; Wang, M.; Yang, X.; Zhao, L.; Lan, Z.; Sun, S. Research Progress in the Development of Vaccines against Mycoplasma gallisepticum and Mycoplasma synoviae. Microorganisms 2024, 12, 1699. https://doi.org/10.3390/microorganisms12081699
Wu S, Wang M, Yang X, Zhao L, Lan Z, Sun S. Research Progress in the Development of Vaccines against Mycoplasma gallisepticum and Mycoplasma synoviae. Microorganisms. 2024; 12(8):1699. https://doi.org/10.3390/microorganisms12081699
Chicago/Turabian StyleWu, Shaopeng, Miaoli Wang, Xiaoxue Yang, Lu Zhao, Zouran Lan, and Shuhong Sun. 2024. "Research Progress in the Development of Vaccines against Mycoplasma gallisepticum and Mycoplasma synoviae" Microorganisms 12, no. 8: 1699. https://doi.org/10.3390/microorganisms12081699